|
|
|
|
EnbrelPhiladelphia Inquirer, ...buy Immunex Corp. and its Enbrel medicine, approved to treat rheumatoid arthritis and the skin disease psoriasis. Amgen paid $1.4 ... New treatments for rheumatoid arthritis Jan 14, 2006 Packet Online, ...new advances in RA treatment involve a new group of anti-inflammatory medications called biologic response modifiers, including Enbrel, Humira, Kineret and ... Wyeth signs three biotech product deals Jan 9, 2006 philly.com, Currently, Wyeth sells seven biologic drugs, including the widely prescribed monoclonal antibody Enbrel for rheumatoid arthritis and the pneumococcal vaccine ... Wyeth forecasts 10 percent EPS growth in 2006 Jan 9, 2006 Reuters Wyeth said it expects international revenue growth for the arthritis drug Enbrel to be in excess of 30 percent in 2006. Wyeth has ... Wyeth, Trubion target arthritis, cancer Jan 3, 2006 Reuters ...$800 million. Wyeth's array of medicines includes the popular monoclonal antibody Enbrel for rheumatoid arthritis. Trubion's most ... Trubion Starts New Year With Potential $840M Wyeth Deal Jan 3, 2006 BioWorld Online (subscription), In fact, both companies have on their development teams researchers and management responsible for developing Enbrel (etanercept), a blockbuster drug for ... Psoriasis Drug May Also Clear Up Depression and Fatigue Dec 15, 2005 CNN 15 - At the same time that Enbrel (etanercept), a tumor necrosis factor-alpha (TNF-a) inhibitor, relieves the clinical symptoms of psoriasis, it may also clear ... Psoriasis drug may also cut depression: study Dec 15, 2005 Reuters.uk, LONDON (Reuters) - Amgen Inc.'s psoriasis drug Enbrel appears to reduce depression and fatigue, as well as improving symptoms of the chronic skin disease ... Psoriasis drug may treat depression, fatigue Dec 20, 2005 myDNA.com, A new study shows that the psoriasis drug called Enbrel (etanercept), made by the California-based Amgen company, appears to also reduce depression and fatigue ... Wyeth, Trubion forge drug-development deal Jan 3, 2006 Reuters Wyeth, whose wide product line includes the popular rheumatoid arthritis drug Enbrel, said Trubion's most important product is an experimental drug for the ... Outlook For Drugmakers Is Mixed Jan 12, 2006 TheDay (subscription), ...be driven by sales of Aranesp, a treatment for anemia in people with chronic renal failure and cancer patients on chemotherapy, as well as Enbrel, a treatment ... News For Your Web Site Jan 9, 2006 dBusinessNews Seattle (press release), Dr. Smith and Dr. Ray Goodwin, a member of VLST's scientific advisory board, were co-inventors of Enbrel(R), a multi-billion-dollar biologic therapy developed ... Amgen, Wyeth win court ruling on patent for arthritis drug Dec 24, 2005 Ventura County Star (subscription), Amgen Inc. and Wyeth won a court ruling that will end a lawsuit by an Israeli company seeking royalties on the arthritis treatment Enbrel. ... Drug May Cut Psoriasis Depression Dec 15, 2005 WebMD Dec. 15, 2005 -- Enbrel, a drug approved to treat rheumatoid and psoriatic arthritis, might also help psoriasis patients mentally and physically. ... Bristol Climbs on FDA Approval Dec 27, 2005 Red Herring, However, the company faces competition from some older medications, such as Johnson & Johnson’s Remicade and Amgen’s Enbrel. ... Bristol-Myers gets FDA approval for arthritis drug Dec 24, 2005 Economic Times, ...therapies. Older treatments include Abbott Laboratories Inc's Humira, Johnson & Johnson's Remicade and Amgen Inc's Enbrel. Three ... Wyeth 2006 forecast misses Street views Jan 9, 2006 San Jose Mercury News, Essner noted Effexor, Enbrel for rheumatoid arthritis and Wyeth's infant formula and other nutritional products all should report $1 billion in revenues from ... Seattle biotech strikes deal with drug giant Jan 4, 2006 Seattle Post Intelligencer Several executives and researchers from the two companies worked together to develop Enbrel, the rheumatoid arthritis drug developed in the Seattle ... Medicare expands tier pricing system Jan 3, 2006 USA Today ...most commonly pay 25% to 33% of the cost of the drug rather than a flat dollar amount — are such expensive treatments as Remicade and Enbrel for rheumatoid ... New Drugs Offer More Choices for Psoriasis Dec 21, 2005 Spartanburg Herald Journal (subscription), 2003, biologic drugs approved for psoriatic arthritis or psoriasis include Remicade; alefacept, sold as Amevive; etanercept, sold as Enbrel; efalizumab, sold ... Trigger for Common Skin Disease Found Jan 10, 2006 Newswise (press release) Current treatments for psoriasis such as the drug Enbrel focus on these inflammatory hormones, but the researchers were able to stop the development of ... Bristol-Myers Squibb Receives US Approval for Arthritis Drug Dec 23, 2005 New York Times, ...status. Orencia will compete with Enbrel by Amgen, Remicade by Johnson & Johnson and Humira by Abbott - all called anti-TNF agents. ... Amgen acquires Abgenix Dec 15, 2005 Boston Globe, The acquisition would be Amgen's biggest since it bought Immunex in 2002 for $8.8 billion, gaining the rheumatoid arthritis drug Enbrel. ... Amgen to acquire Abgenix for $2.2bn Dec 15, 2005 New Ratings The acquisition marks the largest one since Amgen took over Immunex in 2002 for $8.8 billion to gain the rheumatoid arthritis drug Enbrel. ... FDA OKs Bristol-Myers rheumatoid arthritis drug Dec 23, 2005 Herald News Daily, ...one or more other therapies. Older tre - ) Humira, Johnson & Johnson‘s (NYSE: - ) Remic - ) Enbrel. Three Bristol-Myers studies ... Biologic drugs the latest psoriasis weapon Dec 20, 2005 United Press International It as well as Amevive, Enbrel, Humira and Raptiva have been approved to treat psoriasis and psoriatic arthritis since 2003, the newspaper reported. ... Commercial Insight: Disease Modification in Rheumatoid Arthritis ... Dec 20, 2005 Pharmaceutical Business Review However, the recent launch of Enbrel and forecast launch of Humira in this market is expected to push the biologic class above traditional DMARDs by 2010 in ... Amgen Buys a Potential Blockbuster Dec 15, 2005 BusinessWeek As one analyst in the post-deal call pointed out, when Amgen bought Immunex in 2002 for $10 billion, it predicted that Immunex's drug Enbrel for rheumatoid ... Local Residents needed for dermatology studies Dec 14, 2005 KOLO, Iinjectable drugs..Raptiva and Enbrel have been shown to be very affective at treating psoriasis. ... Betty has found relief with the drug Enbrel. ... Easing psoriasis blues Dec 16, 2005 Health24.com, Etanercept, which goes under the brand name Enbrel, works by blocking a protein called tumour necrosis factor-alpha (TNF-alpha), which is produced by the body ... Amgen to Buy Abgenix, Getting Complete Control of New Colon Cancer ... Dec 14, 2005 New York Times, ...discovery prowess. In 2002, it paid about $10 billion for Immunex to obtain the big-selling rheumatoid arthritis drug, Enbrel. The ... Wyeth's Biotech Bet Jan 4, 2006 Motley Fool Several of them worked on Enbrel, the monoclonal antibody for rheumatoid arthritis now marketed by Wyeth and Amgen (Nasdaq: AMGN). ... US okay for B-MS' blockbuster candidate Jan 2, 2006 Pharma Times (subscription), ...such as methotrexate but also the new anti-tumor necrosis factor products such as Johnson & Johnson's Remicade (infliximab), Wyeth's Enbrel (etanercept) and ... Business news in brief Dec 24, 2005 Philadelphia Inquirer, Bloomberg News. Amgen Inc. and Wyeth won a ruling that would end a lawsuit by an Israeli company seeking royalties on the arthritis treatment Enbrel. ... Psoriasis Drug May Also Fight Depression Dec 14, 2005 HealthCentral.com Etanercept, which goes under the brand name Enbrel, works by blocking a protein called tumor necrosis factor-alpha (TNF-alpha), which is produced by the body ... Bristol-Myers Shares Gain in Europe After US Clears Drug Dec 27, 2005 Bloomberg It is more disabling than the more common osteoarthritis form of the disease. Existing treatments for rheumatoid arthritis include Enbrel, sold by Amgen Inc. ... Bristol-Myers shrs up 2 pct after Orencia approval Dec 27, 2005 Washington Post, ...treatments. Those treatments include big-selling drugs, such as Amgen Inc.'s Enbrel and Johnson & Johnson Inc.'s Remicade. "The ... Bristol-Myers shrs up 2 pct after Orencia approval Dec 27, 2005 Reuters Those treatments include big-selling drugs, such as Amgen Inc.'s (AMGN.O: Quote, Profile, Research) Enbrel and Johnson & Johnson Inc.'s (JNJ.N: Quote, Profile ... Bristol-Myers Wins FDA Approval for Orencia Treatment (Update2) Dec 23, 2005 Bloomberg Existing treatments for rheumatoid arthritis include Enbrel, sold by Amgen Inc. and Wyeth, Johnson & Johnson's Remicade and Abbott Laboratories' Humira. ... Abgenix German Shares Jump on Amgen's $2.2 Billion Cash Offer Dec 15, 2005 Bloomberg It would be Amgen's biggest transaction since the company bought Immunex in 2002 for $8.8 billion, gaining the rheumatoid arthritis drug Enbrel. ... S&P Upgrades Univision to Strong Buy Dec 27, 2005 BusinessWeek However, its potential is limited by the FDA's restriction of the drug to patients who fail to respond to existing drugs, such as Enbrel and Remicade. ... Amgen initiated with "buy" Dec 16, 2005 New Ratings ...this morning, the analyst mentions that the performance of Amgen's core business remains robust, driven by the company's Aranesp, Neulasta and Enbrel drugs. ... Zacks.com announces that Nadine Wong highlights: Abgenix and Amgen Dec 21, 2005 Business Wire (press release), ...growth. Despite changes to Medicare reimbursement, the company will remain competitive in the EPO and Enbrel markets. Successful ... Wyeth opens Dublin drug discovery research facility Dec 22, 2005 DrugResearcher.com, With more than $17.4 billion in revenue this includes such innovative products as the rheumatoid arthritis drug Enbrel (etanercept), ReFacto (antihemophilic ... Duke in the News: Dec. 15, 2005 Dec 15, 2005 Duke University, 14 -- The psoriasis drug Enbrel appears to reduce depression and fatigue, as well as improving symptoms of the chronic skin disease, Duke researchers say. ... ... Juvenile Arthritis - A Niche In The Market Dec 20, 2005 Pharmaceutical Business Review ...for tax credit and marketing incentives, and all three biologic TNF-inhibitors currently have orphan designation in the US but only Enbrel (etanercept) is ... Wyeth to establish a Bio-therapeutic Drug Discovery Research ... Dec 21, 2005 Biotechnology Ireland, Crohn's disease and a range of other complaints; Fusion Proteins, which is a class of drugs that is exemplified by Wyeth's flagship product, Enbrel, used for ... Amgen's blockbuster anemia drugs facing patent challenge Dec 24, 2005 Providence Journal (subscription), But Amgen, the world's largest biotechnology company, which manufactures the rheumatoid arthritis drug Enbrel in West Greenwich, will not give up its empire ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |